VERU
Veru Inc
NASDAQ: VERU · HEALTHCARE · BIOTECHNOLOGY
$2.25
+0.45% today
Updated 2026-04-30
Market cap
$36.76M
P/E ratio
—
P/S ratio
1.79x
EPS (TTM)
$-1.21
Dividend yield
—
52W range
$2 – $7
Volume
0.1M
Veru Inc (VERU) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-60.30%
ROA
-42.90%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | $14.82M | $282026.00 | 37.03% | 1.62% | 1.90% |
| 2007 | $19.32M | $1.69M | 37.04% | 4.53% | 8.77% |
| 2008 | $25.63M | $4.97M | 41.86% | 12.42% | 19.38% |
| 2009 | $27.54M | $6.54M | 49.08% | 17.13% | 23.73% |
| 2010 | $22.22M | $6.74M | 58.16% | 19.57% | 30.32% |
| 2011 | $18.57M | $5.40M | 53.14% | 17.75% | 29.08% |
| 2012 | $35.03M | $15.30M | 58.86% | 31.23% | 43.67% |
| 2013 | $31.46M | $14.34M | 55.65% | 31.12% | 45.59% |
| 2014 | $24.49M | $2.43M | 53.58% | 16.02% | 9.93% |
| 2015 | $32.60M | $4.35M | 58.18% | 20.30% | 13.33% |
| 2016 | $22.13M | $344725.00 | 60.33% | 13.64% | 1.56% |
| 2017 | $13.66M | $-6.61M | 51.40% | -62.20% | -48.42% |
| 2018 | $15.86M | $-23.94M | 55.36% | -131.57% | -150.89% |
| 2019 | $31.80M | $-12.02M | 68.10% | -20.24% | -37.79% |
| 2020 | $42.59M | $-18.97M | 72.28% | -34.62% | -44.55% |
| 2021 | $61.26M | $7.39M | 78.24% | 21.18% | 12.07% |
| 2022 | $39.35M | $-83.78M | 77.73% | -211.47% | -212.88% |
| 2023 | $16.30M | $-93.15M | 46.43% | -575.46% | -571.60% |
| 2024 | $16.89M | $-37.80M | 34.67% | -218.61% | -223.86% |
| 2025 | $0.00 | $-22.73M | — | — | — |